Oktay Halit Aktepe, Fadime Sinem Ardic, Deniz Yuce, Deniz Can Guven, Gurkan Guner, Hasan Cagri Yildirim, Saadettin Kilickap, Alev Turker, Neyran Kertmen, Serkan Akin, Sercan Aksoy, Omer Dizdar, Suayib Yalcin, Mustafa Erman
PURPOSE: The objective of the present study was to compare the efficacy of axitinib and nivolumab in metastatic renal cell carcinoma (mRCC) previously treated with targeted therapy. METHODS: A total of 79 patients were enrolled (39 patients in axitinib group, 40 patients in nivolumab group). Survival outcomes of patients, progression-free survival (PFS), and overall survival (OS) were estimated using the Kaplan-Meier method and compared with the log-rank test. The associations between potential prognostic variables and OS were evaluated in univariate and multivariate Cox regression analyses...
September 2021: Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology